Business
Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record Growth
Beijing Fangyixing Information Technology Co., Ltd. ("Fangyixing"), a subsidiary of China's leading Internet healthcare solutions provider Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), has been certified as a 2024 National High-Tech Enterprise, solidifying its role as a pioneer in AI-powered healthcare innovation. The designation, jointly awarded by the Beijing Science and Technology Commission, Beijing Finance Bureau and Beijing Municipal Tax Service, recognizes Fangyixing's strengths
About this update from Fangzhou Inc.
[{"type":"text","content":"BEIJING, April 3, 2025 /PRNewswire/ -- Beijing Fangyixing Information Technology Co., Ltd. ("Fangyixing"), a subsidiary of China's leading Internet healthcare solutions provider Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), has been certified as a 2024 National High-Tech Enterprise, solidifying its role as a pioneer in AI-powered healthcare innovation. The designation, jointly awarded by the Beijing Science and Technology Commission, Beijing Finance Bureau and Beijing Municipal Tax Service, recognizes Fangyixing's strengths in core intellectual property, commercialization of scientific achievements, and robust R&D management.","length":690,"tagName":"p"},{"type":"image","alt":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","displaySize":"","headline":null,"caption":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":127,"url":"https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UzhMEweRObfFg12_yi_6IQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342","width":400,"height":127}},"href":"https://mma.prnewswire.com/media/2544392/Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, commented, "This honor validates our long-term commitment to R&D and empowers us to further scale AI innovations within our H2H Smart Healthcare Ecosystem. We will continue to deepen collaborations with industry leaders and accelerate the translation of cutting-edge research into accessible and life-changing healthcare solutions."","length":403,"tagName":"p"},{"type":"text","content":"Strong Financial Performance Driven by Robust Innovation","length":56,"tagName":"p"},{"type":"text","content":"Fangzhou's inaugural post-IPO annual results highlighted its dual trajectory of growth and innovation: 2024 revenue grew 11.2% YoY to RMB2.707 billion, while adjusted net profit increased by 139% YoY to RMB17.1 million. This significant growth reflects Fangzhou's sustained investment in and focus on AI-enabled technologies as a core driver of business value and operating efficiency.","length":...